Please login to the form below
Isis Pharmacueticals
This page shows the latest Isis Pharmacueticals news and features for those working in and with pharma, biotech and healthcare.
Roche and Isis in $392m deal to research drugs for brain disorder
Will develop antisense drugs for Huntington's disease. Roche is to partner with Isis Pharmaceuticals to research medicines for the Huntington's disease – a rare, genetic brain disorder for which there ... The CHDI Foundation will receive $1.5m as part
Latest news
More from news
Approximately 1 fully matching, plus 0 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- Editor & Senior Editor - Medical Communications - Home Based
-
Highly Competitive Salary, Bonus &Benefits
- FREELANCE Medical Writer, Senior Medical Writer, Principal Medic...
-
Highly Competitive Day Rate, Bonus &Benefits
- Senior Account / Programme Manager - MedComms - Buckinghamshire
-
Highly Competitive Remuneration packages
- Senior Account Director & Associate Director - Healthcare Ad...
-
Highly Competitive Salary, Bonus &Benefits
- Medical Writer, Senior Medical Writer, Principal Medical Writer,...
-
Highly Competitive Salary, Bonus &Benefits
-
Account Manager
-
Competitive Salary
-
Senior Account Executive
-
Competitive Salary
-
Medical Editor
-
Competitive Salary
-
Senior Medical Writer
-
Competitive Salary
- Home Working Medical Copy Writer & Senior Medical Copy Write...
-
Highly Competitive Salary, Bonus &Benefits
- Client Services Director – London or Home Based – Medical Commun...
-
Highly Competitive Salary, Bonus &Benefits
-
Associate Account Director
-
Competitive Salary
- Freelance Medical Writer - Creative Healthcare Comms - 2 month t...
-
Excellent Day Rate
- Senior Content Editor - Biotechnology
-
Salary TBC
- Senior Leadership Role – Medical Communications – North West
-
Highly Competitive Salary, Bonus &Benefits
- CureVac outlines COVID-19 vaccine production plans ahead of regulatory approval
- Moderna’s booster vaccine for South African variant demonstrates promising early results
- Janssen will not seek regulatory approval for Erleada plus Zytiga in prostate cancer
- Merck & Co halts development of potential COVID-19 drug MK-7110
- Roche’s Ocrevus shows significant benefit in early-stage MS patients
- Novavax seeks FDA emergency approval for COVID-19 vaccine by May
- Leaders in Pharma: Samir Vattompadam
- Building Better Access to Pediatric Care Through Telehealth
- Building trust through sustainability communications
- Healthware Group acquires London-headquartered consultancy SWM
- Lucid Group promotes Clare Reynolds to Director of Business Development and Commercial Integration
- Are you ready for the digital health revolution?
PMHub
Wilmington Healthcare
A heritage to envy Wilmington Healthcare brings together the data intelligence specialisms of Binley’s, NHiS, Wellards and HSJ to create...
Latest intelligence
- Are you ready for the digital health revolution?
- In this edition of Delta magazine, we explore how rapid digitalization has transformed the care pathway and reveal how life science companies can succeed in the digital age....
- #DemandDiversity: Can new medical publication guidelines help fix diversity in clinical trials?
- Over the last 8 months, JAMA have been working on a new set of guidelines for research papers looking to publish with them, which is summarised in their latest editorial...
- Empowering patients empowers results
- Patient-centricity is key when it comes to creating a more flexible, efficient and modern process for clinical trials...
Quick links
Infographics
